Graham Cooper
Président chez KEZAR LIFE SCIENCES, INC.
Fortune : - $ au 31/05/2024
Provenance du réseau au premier degré de Graham Cooper
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve.
521
| Subsidiary | Investment Banks/Brokers | 521 |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.
191
| Subsidiary | Miscellaneous Commercial Services | 191 |
| Public Company | Biotechnology | 25 | |
| Subsidiary | Pharmaceuticals: Major | 24 | |
| Public Company | Biotechnology | 23 | |
20
| Subsidiary | Pharmaceuticals: Major | 20 |
| Public Company | Biotechnology | 19 | |
Celladon Corp.
 Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA.
13
| Extinct | Biotechnology | 13 |
| Public Company | Biotechnology | 13 | |
| Public Company | Biotechnology | 8 | |
| Public Company | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Graham Cooper via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Masters Business Admin Undergraduate Degree Chairman Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| University of California, Davis | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Founder Private Equity Investor Private Equity Analyst Private Equity Investor Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree Masters Business Admin Doctorate Degree Undergraduate Degree | |
| DENALI THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| GOSSAMER BIO, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Treasurer | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Administrative Officer Corporate Officer/Principal | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Corporate Officer/Principal | |
Orbital Therapeutics, Inc.
 Orbital Therapeutics, Inc. BiotechnologyHealth Technology Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation. | Biotechnology | Founder Founder Director/Board Member Founder | |
| SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Public Communications Contact | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director/Board Member General Counsel Human Resources Officer | |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman Corporate Officer/Principal | |
Aerium Therapeutics, Inc.
 Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Investor Relations Contact | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director of Finance/CFO | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| LYELL IMMUNOPHARMA, INC. | Biotechnology | General Counsel Director/Board Member Chief Tech/Sci/R&D Officer | |
| SANA BIOTECHNOLOGY, INC. | Biotechnology | Founder Director/Board Member Director/Board Member | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| NEUMORA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
Ren Pharmaceuticals, Inc.
 Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ren Pharmaceuticals was formed in the fall of 2006 with the aim of bringing together talented and experienced people who are passionate about building a cardio-renal/renal- focused drug development company. Ren Pharmaceuticals closed a Series A financing in November 2006 with Sanderling Ventures, Venrock Associates and Amgen Ventures as investors. The company's R&D is currently located in South San Francisco, California. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| FATE THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member Chief Executive Officer | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| CELGENE | Biotechnology | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| PRIME MEDICINE, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment ManagersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Investment Managers | Analyst-Equity Analyst-Equity Corporate Officer/Principal | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Founder Director/Board Member | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Director/Board Member Director/Board Member Investor Relations Contact | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 50 |
| Canada | 2 |
Sectorielle
| Health Technology | 33 |
| Consumer Services | 12 |
| Finance | 5 |
| Commercial Services | 4 |
Opérationnelle
| Director/Board Member | 678 |
| Corporate Officer/Principal | 274 |
| Independent Dir/Board Member | 188 |
| Chief Executive Officer | 96 |
| Chairman | 94 |
Relations les plus connectées
| Insiders | |
|---|---|
| Robert Nelsen | 80 |
| Amir Nashat | 51 |
| Douglas Cole | 44 |
| Kristina Burow | 43 |
| Franklin Berger | 41 |
| Stephen Knight | 39 |
| Todd Foley | 38 |
| John Maraganore | 38 |
| Barbara Dalton | 35 |
| Dan Omstead | 33 |
| Larry Marcus | 33 |
| Paul Berns | 28 |
| Kathleen Walsh | 27 |
| Faheem Hasnain | 27 |
| Wendy Dixon | 25 |
- Bourse
- Insiders
- Graham Cooper
- Connexions Sociétés
